Passive

First Trust Indxx Medical Devices ETF

The First Trust Indxx Medical Devices ETF (the “Fund”) seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an index called the Indxx Medical Devices Index (the “Index”).

$19.77

Key Metrics

TER 0.70% per year
Distribution policy Distributing
Fund size USD 2 M
Inception date June 22, 2021
Holdings 50
Fund currency USD
Fund domicile US
Provider First Trust
For full official fund details, factsheets, and holdings, visit ftportfolios.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Indxx Medical Devices ETF MDEV
Fund Size
$1.91M
Dividend
0.1%
Fees
0.70%
Total Stock Market Index Fund VTSAX
Fund Size
$1.99T
Dividend
1.0%
Fees
0.04%
Total Stock Market Index Fund VTI
Fund Size
$1.99T
Dividend
1.1%
Fees
0.03%
500 Index Fund VFIAX
Fund Size
$1.42T
Dividend
1.0%
Fees
0.04%
500 Index Fund VFINX
Fund Size
$1.42T
Dividend
1.0%
Fees
-
View 1339 similar ETFs →

Historical Return

Last updated: Jul 01, 2026
1 Year -7.1% +0.1% Div
3 Years (avg.) -2.6% +0.1% Div
5 Years (avg.) -5.5% +0.1% Div

Risk & Analysis Metrics

Last updated: Jul 01, 2026

Volatility

15.86% 1 Year
16.46% 3 Years
18.97% 5 Years
18.93% 10 Years

Max Drawdown

-17.56% 1 Year
-22.50% 3 Years
-42.34% 5 Years
-42.34% 10 Years

Sharpe Ratio

-0.61 1 Year
-0.33 3 Years
-0.42 5 Years
-0.42 10 Years

Return Triangle (Heatmap)

Last updated: Jul 01, 2026
2021 2022 2023 2024 2025
2021 4.2% -13.5% -7.0% -4.8% -3.8%
2022 -28.2% -12.1% -7.6% -5.6%
2023 7.6% 4.8% 3.4%
2024 2.2% 1.3%
2025 0.5%

Distributions

*by ETF Portfolio Weight Last updated: Jul 01, 2026

Profit Margin Distribution

< 0%
5%
1y 3y N/A N/A
0 - 5%
6%
1y 3y N/A N/A
5 - 10%
28%
1y 3y N/A N/A
10 - 15%
29%
1y 3y N/A N/A
15 - 20%
22%
1y 3y N/A N/A
20 - 30%
8%
1y 3y N/A N/A
30 - 40%
0%
1y 3y N/A N/A
> 40%
3%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
5%
1y 3y N/A N/A
0 - 10
3%
1y 3y N/A N/A
10 - 15
0%
1y 3y N/A N/A
15 - 20
11%
1y 3y N/A N/A
20 - 25
13%
1y 3y N/A N/A
25 - 35
24%
1y 3y N/A N/A
35 - 50
31%
1y 3y N/A N/A
> 50
13%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
2.8%
1y 3y N/A N/A
Mid Cap
10.8%
1y 3y N/A N/A
Large Cap
86.5%
1y 3y N/A N/A
Mega Cap
0.0%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jul 01, 2026
17.3% Top 5 Holdings
31.5% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
GMED Globus Medical Inc
4.1%
ALGN Align Technology, Inc.
3.6%
PEN Penumbra Inc
3.4%
MASI Masimo Corp
3.3%
HOLX Hologic, Inc.
3.0%

Latest News

5 months ago • businesswire.com

Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC...

5 months ago • forbes.com

What's Happening With Masimo Stock?

Masimo stock (MASI) has faced a challenging year, trailing the broader market with a -3% annual return. While shares surged 34% yesterday following...

5 months ago • zacks.com

Strength Seen in Masimo (MASI): Can Its 34.2% Jump Turn into More Strength?

Masimo (MASI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help th...

Average metrics of all companies in portfolio

Last updated: Jun 28, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $41.2B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.73% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.93 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 38.0 28.61
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -7.78 -
Profitable Companies 95% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 29.9 18.04
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 4.5 8.09
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.8 10.18
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 29.8 20.33
Enterprise Value to Revenue Enterprise value divided by revenue 4.62 7.98
Total Debt to Enterprise Value Total debt divided by enterprise value 0.13 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. -0.92 0.27
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 10.49% 20.81%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -14.1% -118.0%
Return on Equity Equity divided by market cap. 10.91% 2.67%
Return on Assets Indicates a company's profitability in relation to its total assets. 6.80% 4.17%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 12.82% 3.72%

Sectors

Manufacturing 62.2%
Health Technology 4.4%
Professional, Scientific, and Technical Services 3.8%
Construction 2.3%
Health Care and Social Assistance 2.1%
Financial Services 2.0%
Healthcare 1.4%
Finance and Insurance 1.4%
Other 20.5%

Countries

United States 55.7%
Japan 7.9%
Switzerland 6.4%
United Kingdom 4.5%
Denmark 4.5%
Germany 3.9%
China 3.9%
Ireland 3.8%
France 3.6%
New Zealand 2.0%
Netherlands 2.0%
Australia 1.4%
Other 0.5%
Other 0.0%

Stock Screener

Select filters to narrow down the 39 investments below

39 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Loading details…

Market Cap $12.78B
P/E Ratio 29.9
Dividends 0.0%
Total Investment $56.57K
Weight 2.97%

Loading details…

Market Cap $12.45B
P/E Ratio 72.3
Dividends 0.0%
Total Investment $52.21K
Weight 2.74%

Loading details…

Market Cap $9.42B
P/E Ratio 125.0
Dividends 0.0%
Total Investment $51.05K
Weight 2.68%

Loading details…

Market Cap $16.97B
P/E Ratio 31.3
Dividends 0.0%
Total Investment $46.26K
Weight 2.43%

Loading details…

Market Cap $24.41B
P/E Ratio 47.5
Dividends 0.0%
Total Investment $46.16K
Weight 2.42%

Loading details…

Market Cap $52.27B
P/E Ratio 48.0
Dividends 0.0%
Total Investment $44.92K
Weight 2.36%

Loading details…

Market Cap $143.33B
P/E Ratio 48.4
Dividends 0.0%
Total Investment $44.26K
Weight 2.32%

Loading details…

Market Cap $33.07B
P/E Ratio 40.8
Dividends 0.5%
Total Investment $43.39K
Weight 2.28%

Loading details…

Market Cap $13.85B
P/E Ratio 60.2
Dividends 0.0%
Total Investment $43.33K
Weight 2.27%

Loading details…

Loading details…

Market Cap $25.54B
P/E Ratio 29.6
Dividends 0.0%
Total Investment $41.62K
Weight 2.18%

Loading details…

Market Cap $29.91B
P/E Ratio 19.9
Dividends 0.2%
Total Investment $41.57K
Weight 2.18%

Loading details…

Market Cap $5.75B
P/E Ratio -5.7
Dividends 1.0%
Total Investment $41.5K
Weight 2.18%

Loading details…

Market Cap $26.32B
P/E Ratio 23.4
Dividends 3.6%
Total Investment $41.3K
Weight 2.17%

Loading details…

Market Cap $14.46B
P/E Ratio 53.8
Dividends 0.2%
Total Investment $41.18K
Weight 2.16%

Loading details…

Market Cap $21.32B
P/E Ratio 47.3
Dividends 0.9%
Total Investment $40.07K
Weight 2.10%

Loading details…

Market Cap $27.07B
P/E Ratio 29.2
Dividends 0.0%
Total Investment $40K
Weight 2.10%

Loading details…

Market Cap $18.01B
P/E Ratio 24.1
Dividends 1.0%
Total Investment $39.6K
Weight 2.08%

Loading details…

Loading details…